Podcasts about Early Stage

Ryan Lee, Senior VP at Direxion, discusses the ongoing AI-driven surge in semiconductor stocks and highlights tools like the SOXL ETF and a Micron (MU)-focused product. He notes the AI cycle is still in its early stages, supporting continued growth across the space. Lee points to broad exposure in SOXL, including AMD Inc. (AMD), Nvidia (NVDA), Marvell (MRVL), Intel (INTC), ASML Holding (ASML), and TSMC (TSM).======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

How did HG Ventures quietly become one of the most active water tech investors on the planet, without even calling itself a water VC?HG Ventures is the corporate venture capital arm of The Heritage Group, a 100-year-old, family-owned Indianapolis conglomerate active in asphalt, quarries, environmental services and specialty chemicals. With $350M in assets, the fund deploys around $50M a year across 41 portfolio companies and 7 sectors, and ranks 5th globally in water tech by deal count despite water being only 18% of its thesis.Ginger Rothrock holds a PhD in chemistry from UNC Chapel Hill, co-founded the NASDAQ-listed pharmaceutical company Liquidia, was promoted to Managing Director of HG Ventures in December 2025, and is a Global Corporate Venturing Rising Star and Kauffman Fellow with deep expertise in industrial water, industrial wastewater treatment, and corporate venture capital in cleantech.

In this episode of the For Construction Pros Digging Deeper podcast, join Joe Cavanaugh, P.E., VP and GM of Geopier, a division of CMC, to discover more about the company and what they can do to ensure construction projects get off the ground on the right foot.

Commentary by Dr. Jian'an Wang.

At the 2026 American Society of Clinical Oncology Annual Meeting, Dr. Jennifer Ligibel, director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute, presented early results from the Breast Cancer Weight Loss (BWEL) study. The findings showed that among women with early-stage breast cancer, losing weight led to better physical and mental health, and also helped ease fatigue. Listen to the episode to hear Dr. Ligibel explain: the design of the BWEL study why the women in the study had to have hormone receptor-positive, HER2-negative or triple-negative breast cancer the next steps for the study

Origins hosts Nick Chirls (GP, Asylum Ventures) and Beezer Clarkson (LP, Sapphire Partners) react to their conversation with Nicholas Csicsko, a public/private investor at Trinity. They dig into his framing of “cynical optimism” and why it might be the right posture for venture investing, unpack the growing obsolescence risk for SaaS companies from earlier vintages, and cap it off with a live question: if sovereign wealth pulls back from US venture, what breaks first?For a monthly roundup of the latest venture insights, including the newest Origins episodes, subscribe to the OpenLP newsletter – delivered straight to your inbox: https://subscribe.openlp.vcCHAPTERS:00:00 Welcome to Origins00:54 Musicians as Investors01:39 Cynical Optimism Explained02:47 Investor Role Beyond Cheerleading03:11 Steadying Founder Emotions05:59 SaaS Obsolete Before Liquidity07:06 Old SaaS Playbook Breaks08:00 Lovable Growth Reality Check09:01 Creative Destruction Across Portfolios10:17 LP Optimism and Venture Nuance11:26 Ugly Truths About Great InvestorsLearn more about OpenLP: https://openlp.vcLearn more about Asylum Ventures: https://asylum.vcLearn more about Sapphire Partners: https://sapphire.vc

Crash preps for his Cypher campaign by writing up an NPC description for future use. This series is heavily inspired by Mike Shea of Sly Flourish recording his own game prep. Follow this series on… Let’s Make RSS Feed: https://aaronbsmith.com/cogwheel/tag/lets-make/feed/ Patreon: https://www.patreon.com/cogwheelgaming Mastodon: https://is.aaronbsmith.com/@cogwheel Not on Mastodon? Consider these instances: gamepad.club dice.camp mastodon.art chirp.enworld.org tabletop.vip MP3 Download: Let’s Make an NPC Ep 6: Integrated (Early Stage) (Cypher System) Art and Markdown Files (NPCs are under a the Filthy Human Hands 1.0 License, art is released in the public domain.) Music Used: Bubble Machine by Drozerix is public domain and can be downloaded from modarchive.org. Keep us ad free by supporting us on Patreon! Thanks to our current Patreon Patrons (as of this upload…): Ellie, Liv Dromen, Paul, ShanShen, Walter, & Patron Emeritus Cindy!

This week on Swimming with Allocators, growth-investor-turned-LP Yuri Lee (TMRS) joins Earnest and Alexa and explains how her global upbringing and love of technology shaped her investing philosophy and belief that talent can come from anywhere. She walks through TMRS's $3B and growing venture/growth mandate, how they split exposure between early-stage and multi-stage funds, and why they are building an aggressive 50/50 funds and co-investment program. Yuri shares what she looks for in emerging managers in clear, differentiated edge in sourcing, picking, or winning; true product–market fit between a manager's edge and fund strategy; and non-consensus, outlier ideas. Throughout, she offers candid advice on how GPs can better pitch institutional LPs, why most decks sound the same, and what it really takes to stand out in a consensus-heavy, AI-dominated market. Also, Chuck Daly of Sidley talks about how emerging VC managers should think proactively about compliance, conflicts of interest, disclosure, and performance/marketing practices under (and aligned with) the Advisers Act and SEC's marketing rule principles. Highlights from this week's conversation include: How a Global Upbringing Shapes an Investor's Worldview (0:13) Consumer Investing and Game Development Experience (2:22) Market Cycles in SaaS and Consumer Narratives (4:19) TMRS Mandate and Building a New Venture Program (6:16) Early Stage Managers and Differentiated, Non-Consensus Portfolios (9:20) What Matters Most at Early Stage vs Growth Stage (12:08) What LPs Really Want to Hear About: Companies and Decisions (14:11) How Pensions and Institutional LPs Run Diligence (17:04) Managing Portfolio Company Synergies and Conflicts (23:56) Marketing Rule Principles, Performance, and Case Studies (26:21) Why TMRS Uses Co-Invests and Target Mix With Funds (30:15) Barbell Approach: Early Stage Funds and Later Stage Co Invests (32:02) Information Gaps for LPs vs GPs and Founder Access (35:55) Consensus Rounds, Party Rounds, and Manager Profiles (38:56) Role of Non-Consensus Managers and Unique Edges (42:09) Rethinking AI Thesis and Value Capture by Model Labs (43:22) Advice For GPs Moving to LP Roles and Building Empathy (45:20) Final Thoughts and Takeaways (47:18) The Texas Municipal Retirement System is a $48+ billion public pension plan serving employees of participating Texas cities. TMRS invests across a diversified portfolio including public equities, fixed income, real assets, and private equity, with venture and growth investments forming an important component of its private markets strategy. Sidley Austin LLP is a premier global law firm with a dedicated Venture Funds practice, advising top venture capital firms, institutional investors, and private equity sponsors on fund formation, investment structuring, and regulatory compliance. With deep expertise across private markets, Sidley provides strategic legal counsel to help funds scale effectively. Learn more at sidley.com. Swimming with Allocators is a podcast that dives into the intriguing world of Venture Capital from an LP (Limited Partner) perspective. Hosts Alexa Binns and Earnest Sweat are seasoned professionals who have donned various hats in the VC ecosystem. Each episode, we explore where the future opportunities lie in the VC landscape with insights from top LPs on their investment strategies and industry experts shedding light on emerging trends and technologies.  The information provided on this podcast does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this podcast are for general informational purposes only. Learn more about your ad choices. Visit megaphone.fm/adchoices

Please visit answersincme.com/860/101385133-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Peter A. Fasching, MD; Michael Gnant, MD, FACS; and Cristina Saura Manich, MD, PhD. In this activity, experts in breast cancer discuss new evidence in neoadjuvant and adjuvant care of early disease. Upon completion of this activity, participants should be better able to: Describe multidisciplinary viewpoints on the role that HER2-directed ADCs may play in the (neo)adjuvant setting for HER2-positive early-stage breast cancer; Evaluate evidence for the (neo)adjuvant use of HER2-directed ADCs in the multidisciplinary management of HER2-positive early-stage breast cancer; and Formulate evidence-based multidisciplinary strategies to optimally incorporate (neo)adjuvant HER2-directed ADCs into the treatment paradigm for HER2-positive early-stage breast cancer.

The following article of the Finance & Fintech industry is: “Early-Stage Investment: A New Angel Opportunity in Latin America” by Maca Lara Dillon, CEO and Founder, Kipus.

A re-release from 2017 but still valid. I've worked with people with CRPS since the early 1980's If you want to discuss treatment options to help book a conversation  Check out my website there is a page about specialist help for persistent and complex pain conditions I work with https://jillwigmore-welsh.com/specialist-chronic-pain   Complex Regional Pain Syndrome, CRPS Chronic Pain, Early Stages Treatment in Reading, London and UK wide via webcam  I'm in the UK and provide holistic evidence informed treatment in the UK and for UK registered residents but who travel all around the world.  I also provide movement lessons around the world, these are educational and not therapeutic, they provide you with tools to begin safely and kindly reconnecting with your body. If you have CRPS you are welcome to contact me for help, I am particularly interested in working with neurodivergent individuals interested in lifestyle and behaviour change, neuroscience, improving sleep, reducing inflammation, managing anxiety, and improving quality of life. 

In this episode of In Demand, Asia and Kim dive into product management. They cover problem space versus solution space and why so many founders and product teams build features based on assumptions, customer requests, or competitive pressure without doing the discovery work necessary to understand what users are actually trying to accomplish. This episode is a masterclass on how to avoid building features nobody uses and how to create products that customers genuinely adopt, value, and pay for. Got a question you'd like Asia to unpack on the podcast? Record a voicemail here. Links:  DemandMaven Subscribe to The Work by DemandMaven on Substack The Lean Product Playbook by Dan Olsen Playing to Win: How Strategy Really Works  Continuous Discovery Habits by Theresa Torres Chapters (00:01:00) - Product discovery and idea validation.(00:03:15) - Why understanding the problem deeply creates better product decisions.(00:06:05) - What product discovery actually means in practice.(00:14:40) - Observational research and watching users interact with products.(00:16:15) - User stories versus hypothetical behavior.(00:19:50) - An example of the user stories you might look for on a SaaS reporting function.(00:23:45) - How support tickets can help lead you to the areas you should start working on.(00:29:00) - Castos example: uncovering integration problems through user stories.(00:37:45) - Theresa Torres and the Continuous Discovery approach.(00:44:30) - How discovery creates clearer product strategy and positioning.

Guest Dr. Glenwood Goss discuss JCO article, "Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer" and the implications of minimal residual disease,  results regarding the efficacy of immunotherapy in the adjuvant setting, and the evolving strategies for patient care in lung cancer treatment. LINK TO FULL TRANSCRIPT

We're going to cure cancer in our lifetime." It's a rallying cry at every charity event, every fundraiser, every race. But what does that actually mean?Dr. Sonal Gandhi, a medical oncologist, joins Ditch the Labcoat to break down what most people don't understand: we already cure cancer. All the time. Early stage cancers like breast, colon, and skin cancer caught in time have cure rates approaching 90 to 100 percent.The challenge is stage four cancer. Metastatic disease. Cancer that has spread to other organs. And even there, the conversation is shifting. Cancer is increasingly becoming a chronic illness. People are living longer with it, sometimes dying with it rather than from it, just like they do with heart disease or diabetes.Dr. Gandhi walks through what "curing cancer" really means, how treatment has evolved beyond chemotherapy into targeted therapies and immunotherapy, and why prevention matters. Up to 40 percent of cancers are related to modifiable lifestyle factors: smoking, alcohol, obesity, lack of exercise. But even doing everything right doesn't guarantee you won't get cancer. Age is the number one risk factor, and we can't modify that.She also challenges the guilt people carry when they're diagnosed and reframes the fear around the "C word." Maybe it's time to pull cancer back into the middle with the menu of other chronic illnesses we manage, not cure.If you've ever wondered what "curing cancer" actually means, why some cancers are more treatable than others, or what you can do to reduce your risk, this episode will reframe how you think about one of medicine's most feared diagnoses.If you've ever wondered why so many people have unexplained symptoms, why standard treatments fail them, or what actually works when medicine runs out of answers, this episode will reframe how you see chronic illness.Dr. Sonal Gandhi's LinkedinEpisode Takeaways1. We already cure cancer. Early stage cancers (stage 1 or 2) caught in time have cure rates approaching 90 to 100 percent, depending on the type.2. Cancer is not one disease. It's dozens of diseases with different stages, treatments, and outcomes. We're better at treating some than others.3. Stage four (metastatic) cancer is increasingly becoming a chronic illness. Treatments help people live longer with cancer, sometimes dying with it rather than from it.4. Up to 40 percent of cancers are related to modifiable lifestyle factors: smoking, alcohol, obesity, and lack of exercise. Being a healthy weight matters for cancer prevention.5. Age is the number one risk factor for cancer. Every decade you get older, cells get worse at repairing mistakes. We can't modify aging.6. Only 10 to 20 percent of cancers are due to inherited genes. Most cancers happen because of the complicated interplay between lifestyle, environment, and cellular aging.7. Immunotherapy works by preventing cancer cells from turning off the immune system, but it can cause severe autoimmune side effects that need rapid treatment.8. Whole body scans and experimental blood tests sound appealing, but they often create more harm than good. Screening needs to be done in context with clear downstream action plans.Episode Timestamps03:51 – What Does "Curing Cancer" Actually Mean?08:15 – Early Stage vs. Late Stage Cancer: The Critical Difference12:42 – How Chemotherapy, Targeted Therapy, and Immunotherapy Work18:35 – Prevention: Lifestyle Factors That Reduce Cancer Risk21:50 – Why Immunotherapy Can Cause Severe Side Effects30:48 – Cancer as a Chronic Illness, Not a Death Sentence38:22 – Environmental and Occupational Cancer Risks45:51 – Why Whole Body Scans Aren't the AnswerDISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.    Disclosures: Ditch The Lab Coat podcast is produced by (soundsdebatable.com) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University.

Dolores trustees voted to let an early-stage housing and commercial development concept move forward after residents raised concerns about traffic, parking, building height and neighborhood impacts.

Vikram Malhotra, managing director, real estate equities at Mizuho, joined the REIT Report to review trends in the industrial/logistics REIT sector. Despite some softness in the first quarter, a new upcycle remains in place, with big box demand playing a key role, he said.Warehouses of over 500,000 square feet have done “very well,” Malhotra said, as companies like Walmart and Amazon adapt to the necessity of quick, last-mile distribution. Mizuho currently estimates overall sector vacancy at 7.5%. That rate is close to peaking, Malhotra said, and then should modestly trend down. “Until we see vacancy trend to about 6%, I think it'll be really hard to see real rent growth…I think we're at least a year away from a very strong market trend.”As for the impact of current global instability, Malhotra noted that “in the very near term, spot demand is strong, but we are monitoring factors where we could see a sign of a pause.”  Instability is likely to strengthen the reshoring trend that has been a theme for the past few years, Malhotra added. Despite the ongoing conflict, the demand for logistics space is expected to reach 150-200 million square feet annually, a significant uptick from previous years.Chapters:00:00 AI Sparks Logistics Upside 00:57 Industrial Outlook 2026 01:44 Big Box Demand Split 02:33 Conflict Impact Check 03:54 Supply Chains And Data Centers 05:54 Markets Supply Risk 2026 07:55 Vacancy And Rent Path 09:07 Warehouse Design Shifts 10:49 Power And Automation Edge 11:59 AI Driven E Commerce Cycle 12:49 Wrap Up And Subscribe

I want you to think about someone in the early phase of coaching, or even someone further along, who needs a reframe and a new perspective in how they're looking at their coaching process. They're asking good questions. They're excited. They're paying attention. They're engaged in what they're doing. And when I hear certain questions around fat loss, I can quickly tell where the disconnect is. The question itself gives insight into how fat loss is being understood, and that understanding drives the decisions and the emotions that follow. It shapes whether you're making choices that move you forward into a stronger, more informed version of yourself, or whether you're stepping back into recognizable patterns that keep you repeating the same old cycle. So today, I want to walk you through some of the most common fat loss questions that came directly from a recent Zoom we hosted inside the SF coaching method for both new and current clients. And more importantly, I want to show you how much those questions actually reveal. Because when you start looking at fat loss through the right lens, everything about your expectations, your timeline, and your decisions begin to shift.   Time Stamps:   (0:42) The Early Stages of Coaching (5:40) Our Added Layer of Support (7:02) Why Isn't The Scale Moving Yet? (11:54) A More Capable System (16:10) Finding Maintenance Calories (18:35) Interpretation ----------  Apply for SF Coaching Method  https://sarahfechter.ac-page.com/sfhq-cc Complimentary Health Content  https://sarahfechter.ac-page.com/Health_Wellness_Community ----------  Follow Me On Instagram - https://www.instagram.com/sarahfechter.ifbbpro/   Check Out My Website - https://www.sarahfechter.com ----------  This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, other professional health care services, or any professional practice of any kind. Any reliance on the information provided in this Podcast is done at your own risk and Sarah Fechter Fitness LLC expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential or other damages arising out of any individual use of, reference to, reliance on, or inability to use, this Podcast or the information presented in this Podcast. All contents and design for this Podcast are owned by Sarah Fechter Fitness LLC. Always consult your professional team before beginning any exercise or nutrition program.

At the University of Nevada, Reno, researchers are combining robotics, artificial intelligence, and agriculture. The early stages of this research give insight into the sheep industry's future.

Welcome to the VRA Investing Podcast with your host, Kip Herriage. In today's brisk Wednesday episode, Kip Herriage breaks down a packed afternoon in the markets, covering major moves following the Fed meeting and the latest earnings reports from tech giants Microsoft, Amazon, Meta, and Alphabet. He also previews the upcoming Parabolic Options Program #25 at VRA, shares why he believes we're still in the early innings of the AI boom, and provides his outlook on oil, gold, Bitcoin, and overall market conditions. Tune in for keen insights on market timing, sector analysis, and stock selection as Kip Herriage explains why the market rally has more room to run, which trends to watch, and how to position for what's ahead.

Arman Mkhitaryan didn't set out to build a business for scale. PostFlow started as a side project, a simple social media scheduling tool built around a familiar workflow.The product worked. It solved a clear use case. But that was the extent of it. Instead of pushing for traction, Arman made a different decision. He listed the product on ⁠⁠Acquire.com⁠⁠ as an early-stage startup and let buyer interest shape the outcome.What followed was not driven by growth metrics. It came down to clarity, product fit, and finding the right buyer.You'll hear:How a clear use case made the product easy to evaluateWhy buyers focused on functionality instead of tractionWhat made the product valuable for internal use3 Lessons from PostFlow's Acquisition:A Clear Use Case Creates Value Early: Even without users or revenue, a product can still attract buyers if it solves a problem in a way that is easy to understand.Not Every Buyer Is Looking to Scale: In this case, the buyer was not interested in growth, but in using the product internally, which changed how the deal was evaluated.Selling Early Is a Strategic Decision: Positioning the product as it was, instead of building more, made it easier to align expectations and move forward.For founders building early-stage startups, this episode shows that scale is not the only path to a successful outcome. What matters is whether the product makes sense to the right buyer.Follow the guest:⁠⁠LinkedIn⁠⁠⁠PostFlow

Closing real estate deals is a multifaceted process that requires meticulous planning and skillful execution. For you to elevate your success rate and achieve more closed deals, it's crucial to pinpoint and effectively address the underlying causes of any challenges you may encounter. In this LIVE coaching episode, Brent Daniels shares invaluable tips on identifying the root issues and paving the way for successfully closing more real estate deals.For more expert advice, make sure to give the TTP Training Program a visit. ---------Show notes:(1:11) Beginning of today's episode(3:30) Understanding Marketing Budgets: Transitioning from Hustle Season to Scaling(4:45) Picking Your Lane: Choosing Between Direct to Seller, Agent Referrals, or Dispositions(6:06) Leveraging Agent Referrals: Using Offers as an Icebreaker to Build a Deal Network(8:20) Becoming a Sniper: Stacking Distress Lists and Targeting "Ugly Houses"(11:45) Case Study: Overcoming Initial Resistance and Identifying Hidden Opportunities(17:11) The Importance of Providing Value by Understanding Local Tax Foreclosure Laws(20:21) Booking an "Appointment from an Appointment" to Ensure Lead Consistency(24:16) Lean Operations: Managing Leads with Low-Cost Tools During the Early Stages(27:50) The Three Seller Factors: Balancing Speed, Convenience, and Price----------Resources:Real SupermarketSkip GenieDeal MachineTo speak with Brent or one of our other expert coaches call (281) 835-4201 or schedule your free discovery call here to learn about our mentorship programs and become part of the TribeGo to Wholesalingincgroup.com to become part of one of the fastest growing Facebook communities in the Wholesaling space. Get all of your burning Wholesaling questions answered, gain access to JV partnerships, and connect with other "success minded" Rhinos in the community.It's 100% free to join. The opportunities in this community  are endless, what are you waiting for?

In this podcast, experts Joyce O'Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A. Wander, MD, PhD; discuss real-world insights into tailoring adjuvant therapy regimens in hormone receptor–positive/HER2-negative (HR+/HER2–) early breast cancer (eBC).

Cristiano Fontana, founder and CEO of Three Bridges, a Milan-based advisory firm helping early-stage MedTech companies navigate the full journey from innovation to market. With over 25 years in the industry starting in the family warehouse handling surgical drains and prostheses as a teenager, Cristiano has a perspective on this business that very few people can match.In this episode, we kick things off with something a little different: a conversation about dressing well, the discipline behind it and why confidence is as much about how you present yourself as what you know. From there, we get into something both of us have strong opinions on. Cristiano breaks down why the conference ROI is so hard to measure, why ghosting has become an epidemic in the industry and why the real payoff from an event can take three years to materialise. He also delivers one of the most honest assessments you'll hear: that early-stage MedTech is just 3% of the industry and that the 97%, the commercial machine that actually drives revenue, is largely invisible to the innovation bubble.We also explore what a better event model could look like, why trust beats value proposition every single time in a crowded advisory market and what innovators consistently get wrong when they think one conference pitch will change everything.Timestamps[00:00:33] Why Dressing Well Is a Form of Discipline, Not Vanity[00:05:00] From the Family Warehouse to 25 Years in MedTech[00:07:48] The 97% vs 3% Split That Nobody in Early Stage Wants to Hear[00:08:37] What MedTech Conferences Are Getting Wrong[00:09:35] The Ghosting Epidemic and What It Reveals About Human Nature[00:10:14] Why Conference ROI Can Take Three Years to Show Up[00:12:30] You Don't Sell on Value Proposition, You Sell on Trust[00:13:17] The Uncomfortable Truth About So-Called Investors at Events[00:20:42] What a Better, More Targeted Event Model Would Look Like[00:30:41] Final Advice: Fill Your Gaps Fast and Stop Seeing Experts as a CostConnect with Cristiano - ⁠⁠⁠https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/Learn more about ThreeBridges - ⁠⁠⁠⁠https://www.threebridges.it/Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠⁠⁠Medical device training courses delivered by Karandeep through Bywater - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.bywater.co.uk/

Paul Hampton, the CEO and one of the founders of investment manager Evonite, talks to Marek Handzel, the editor of Institutional Real Estate Europe about early stage managers. What are the current barriers to entry? How do investors view smaller investment houses? And what can early stage managers offer in this new cycle?

Winners will receive technical support to build a minimum viable product (MVP), worth up to €100,000, and gain access to investors Portugal will host a first-of-its-kind competition for femtech startups and research labs this spring. It will bring together innovators working at the intersection of artificial intelligence and women's health. The initiative, launched by the scientific platform EmbryoNet-AI in partnership with FemTech Real Money Talks Media, a European media platform covering innovation in women's health and femtech, aims to accelerate real-world breakthroughs by transforming early-stage ideas and clinical questions into working AI solutions. FemTech startups event in Portugal this spring "Women's health has been long underfunded, and under-researched. With this competition we want to change that and bring light to talented teams that are moving this field forward", Elena Lipilina, co-founder and CMO of Embryonet AI. Organizers have already launched an open call, which will remain open until 28 April 2026, with all submissions due by midnight CET. It is open for both Portuguese and international teams who have a strong hypothesis and access to imaging or time-series data, and who are seeking to answer critical questions in women's health using AI, whether in drug discovery, diagnostic support, or clinical research. Early-stage startups in women's health that do not yet have a product or MVP are also invited to apply. "We are interested in clinical and drug discovery challenges where AI has the potential to create a meaningful impact in women's health. This includes projects that leverage time-series phenotyping to better understand drug response and disease mechanisms in areas such as gynaecological cancers, endometriosis, and fertility research. We also interested in team that want to accelerate medical image pre-labeling for datasets derived from mammography, pelvic MRI, ultrasound, or pathology slides, as well as solutions that combine phenotypic and clinical data to support decision-making in clinical trials, biomarker discovery, and treatment stratification", shared Lipilina. Among applications, organizers will select up to 10 companies based on their potential impact on women's health, readiness of data, alignment with EmbryoNet-AI's capabilities, feasibility within the program timeframe, and the strength of their business case, alongside ethical and sustainability considerations. These shortlisted teams will move into the next phase—the Mentor Sprint, that will take place in early May 2026. During this period, participants will work closely with experts across technology, marketing, and clinical domains to refine their project scope and strengthen their approach. The program will culminate in a Live Pitch Day in May 2026, where finalists will present their solutions to a panel of investors and experts from the fields of women's health, artificial intelligence, and biotech. The winning team will then enter an 8–10 week build period, running from May to July 2026, during which EmbryoNet-AI will deliver a fully developed, services-first pilot at no cost. According to Lipilina, this will allow the team to save between €65,000 and €100,000—the typical cost of developing an MVP, depending on the product's complexity. The winner will also gain direct access to investors active in women's health and AI-driven biotech, as well as enhanced public credibility through investor-ready materials, including pitch decks, and media exposure. See more breaking stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help p...

Healthcare innovation is having a moment. With over 500 startups applying annually to leading accelerators like Health Wildcatters, the sector is seeing a surge of founders eager to tackle inefficiencies in care delivery, diagnostics, and patient experience. At the same time, digital health is regaining momentum—after a period of market correction, funding went up for the second consecutive year in 2025, reaching a whopping $22.3 billion globally, a rebound that signals renewed but more selective investor confidence. Yet unlike consumer tech, healthcare remains highly regulated, capital-intensive, and slow-moving—raising the stakes for entrepreneurs who get it wrong.So what separates the founders who break through from those who stall out? More importantly, what does a credible healthcare entrepreneur actually look like in today's environment?Welcome to I Don't Care. In the latest episode, Dr. Kevin Stevenson sits down with Dr. Hubert Zajicek, CEO, co-founder, and partner at Health Wildcatters, to unpack what it really takes to build and scale a healthcare startup. From early-stage credibility to funding strategy and founder mindset, the conversation offers a candid look at the realities behind the hype.Top insights from the talk…Credibility comes from experience and proximity to the problem. Most successful founders have deep domain knowledge or firsthand exposure to the issues they're solving.The biggest pitch mistake? Over-indexing on the tech. Investors care more about the problem, go-to-market strategy, and execution than technical minutiae.Money doesn't fix bad fundamentals. Poor product-market fit, weak teams, or the wrong partners can sink a startup regardless of funding.Dr. Hubert Zajicek is a healthcare entrepreneur and investor who co-founded and leads Health Wildcatters, a leading seed accelerator that has supported over 130 early-stage companies and helped them raise more than $350M in funding. He specializes in venture capital, strategic planning, and startup development, with deep expertise in guiding healthcare innovations across digital health, medtech, and biotech from concept to commercialization. In addition to his entrepreneurial leadership, he founded the Health Hacking Crisis Network during COVID-19 and serves as the Austrian Honorary Consul in Dallas, reflecting his broader impact across healthcare, innovation ecosystems, and international relations.

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoarthritis, how it's defined, and why the EsSKOA initiative is changing the way we identify and understand the condition in its earliest phases.Dr. Armaghan Mahmoudian is an Assistant Professor of Movement Sciences and Health at the University of West Florida, where she teaches anatomy and physiology, biomechanics, and research methods, and co-directs the biomechanics and motor learning laboratory. As a clinician-scientist, her research focuses on understanding disease mechanisms and their impact on function and quality of life, with a particular interest in personalised medicine and disease prevention in an ageing population.RESOURCESEsSKOA InitiativeJournal article Reframing early-stage symptomatic knee osteoarthritis (EsSKOA): A strategic lens for trial designCONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Scaling Without Losing the Startup MindsetIn this clip, Vishnu Acharya, Head of Network Infrastructure EMEA at Uber, shares how Uber maintains its early-stage mindset, even at massive scale.Despite growing to thousands of engineers, the focus remains the same:

In this episode of the For Construction Pros Digging Deeper podcast, join Christina Edgerton, lead of commercial development and growth for CMC's early stage construction segment, to discover the company and what they can do for construction projects before problems snowball later in the schedule.

What if the thing keeping your brand stuck isn't effort, but focus? In this episode, Emma breaks down the subtle yet powerful differences between early-stage brands and those that scale with consistency and revenue. She reveals why doing more isn't the answer, and how prioritizing the right things is what truly drives growth. You'll learn why unclear messaging, lack of systems, and relying on guesswork can quietly stall your progress, even when you're showing up consistently. Emma walks through the four essential priorities that scaling brands get right, and introduces a free Social Media Health Check to help you identify exactly where your brand stands and what to focus on next. If you've been feeling like you're doing all the things but not seeing results, this episode will help you simplify your strategy and move forward with clarity and confidence. Listen in as Emma explains: Why clear positioning attracts the right audience and speeds up conversions How conversion systems turn visibility into consistent revenue growth How to employ strategic restraint to grow faster  And much, much more!   Connect with Ninety Five Media: Check out our website: ninetyfivemedia.co  Follow us on Instagram: instagram.com/ninety.five.media   Grow your brand's social media presence with us:  Tell us about your business goals and explore how our social media management services can help you reach them! ninetyfivemedia.co/stop-scrolling-start-scaling-inquiry  NEW FREEBIE! What if I told you your content isn't converting, your audience isn't engaging, and it feels like too much work - not because you're failing, but because your social media needs a check-up? Take our FREE Social Media Health Check today to: ✅ See where your social media stands today ✅ Identify your growth stage ✅ Discover the next step to level up your results Just because you haven't seen results yet doesn't mean it has to stay that way. We're here to help. Ready to find out how you're doing? Take our free Social Media Health Check: https://form.typeform.com/to/XFQqYq27

Runway is launching a $10 million fund and startup program to back companies building with its AI video models, as it pushes toward interactive, real-time “video intelligence” applications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dan McHugh, head of the investment team at Yosemite, explains the San Francisco VC group's approach to investing in early-stage cancer therapeutics and funding academic research through unrestricted grants. Founded by Reed Jobs, son of Steve Jobs and Laurene Powell Jobs, Yosemite invests across drug modalities and supporting technologies in the oncology space. Dan talks about his path from bioengineering to biotech venture capital, meeting Reed Jobs on Stanford's fencing team, his CEO turn at Tune Therapeutics, and the current fundraising environment for innovative science.   Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.  Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Gili Raanan is the Founder of Cyberstarts, one of the best performing venture funds of the last decade. He is famed for being the seed investor in Wiz, Islands and Cyera, leading to multiple 10x+ funds. He has the only remaining monopoly in venture; cyber security in Israel. If it is good, Gili sees it, it is that simple.  AGENDA: 00:00 — Does the Venture Business Even Work Anymore? 05:58 — The Insane Rise of $150M Seed Rounds! 08:58 — Will Mega Funds Ever Actually Return Venture Economics? 11:13 — How Do You Value Companies Growing at Impossible Speeds? 14:50 — The Truth About Growth: Why Most Companies Eventually Plateau 18:50 — Do Margins Still Matter in the Age of AI? 24:32 — How To Make Mega Money in the World of Secondaries 28:11 — What Are Core Misalignments Between GPs and LPs That No One Discusses? 37:57 — Quick Fire: Best Investment, Most Memorable Founder, Investing Icon    

Video episode!Start Summit 2026, an event organized by students in Switzerland. Featuring an elevator and a challenge every entrepreneur knows well: explain a complex idea in 60 seconds without losing what truly matters.From Start Summit 2026 in St. Gallen, we recorded an Intangiblia Flash episode capturing the energy of a place where investors, founders, and inventors come together to accelerate, expand, and turn real technology into reality.The best founders don't treat intellectual property like paperwork, they treat it like strategy. I walk around the Start Summit, talking about patents, trademarks, open-source licensing, and the real reason IP matters to customers and investors. If you're building a startup and wondering what “defensible” actually means, these short interviews make it concrete in minutes. We talk about a dual approach that many deep tech companies overlook: patent the core hardware innovation while keeping software open source under a permissive license to drive adoption and let customers go deep without fear of IP constraints. Then we jump into consumer and assistive tech, including a cat health-monitoring station that measures intake, temperature, and more, plus a smartwatch built for people with cognitive impairments that uses symbols, schedules, and voice prompts. It's a reminder that product design, trust, and usability can be as important to protect as the underlying tech. An experienced investor and company builder shares why IP is a game-changer in biotech, medtech, semiconductors, and industrial technology, especially when partnerships or acquisitions are the likely path to scale. We also touch on common founder pitfalls, like filing too early, and why a strong IP portfolio is something you reinforce over time, not a snapshot you frame once. If you want more founder field notes like this, subscribe, share the episode with a builder friend, and leave a review with the smartest IP lesson you've learned so far. Video episode!Send us Fan MailCheck out "Protection for the Inventive Mind" – available now on Amazon in print and Kindle formats.The views and opinions expressed (by the host and guest(s)) in this podcast are strictly their own and do not necessarily reflect the official policy or position of the entities with which they may be affiliated. This podcast should in no way be construed as promoting or criticizing any particular government policy, institutional position, private interest or commercial entity. Any content provided is for informational and educational purposes only.

Innovation does not just happen among the primary automation suppliers. Innovative ideas need nurturing and time to prove their value. Companies like Emerson can help provide capital and expertise to nurture these innovations happening in these early-stage companies. This is where Emerson Ventures comes in.

In this episode, recorded in Mandarin, host Dr. Chunxia Su leads a discussion about early stage and preoperative care for patients with NSCLC with an EGFR mutation. Guests: Wenzhao Zhong, Deputy Prensendent of Guangdong Provincial People's Hospital, Director of the Cancer Institute, Guangdong Provincial People's Hospital Jie Hu， Deputy director, Department of Respiratory Medicine, Shanghai Geriatric Medical Center，Zhongshan Hospital, Fudan University Min Fan M D， Deputy Director , Department of Radiation Oncology, Fudan University Shanghai Cancer Center

On this episode of Investor Connect, Hall welcomes PPaola Torre, venture partner at Acquilus Ventures and board member at Life Science Angels. Located in the United States, Life Science Angels invests exclusively in early-stage life sciences companies at the seed and early Series A stages, combining capital with deep operational, scientific, and clinical expertise and hands-on mentoring beyond the check. The group emphasizes translational credibility, unmet medical need, team quality, and risk management, pressure-testing IP, regulatory strategy, and timelines, and increasingly values pharma partnerships as predictive for 2026; it also collaborates through syndicates with other angels, VCs, and strategics. Paola is a PhD scientist with hands-on R&D experience at BioMarin Pharmaceutical across fibrosis, neurometabolic disorders, and cardiovascular disease, and she works at the intersection of biotechnology, venture capital, and healthcare innovation. She shares LSA's approach to deal structures and valuation discipline (including a $15M pre-money cap and use of convertible notes), how angels help de-risk capital-intensive biotech, what makes founders successful, and her views on next-generation therapies, AI-enabled platforms, non-animal models, and AI risks, standards, and FDA priorities. Visit www.lifescienceangels.com Reach out to at www.linkedin.com/in/paola-torre-phd/?locale=en_US ________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.

Can 4 Volts of Electricity Replace 60 Bars of Pressure in Seawater Desalination? ilion Water Technologies is a 2025 spinout from the Physics Laboratory of the École Normale Supérieure in Paris. Their VIRO (Voltage-Induced Reverse Osmosis) technology claims to replace the high-pressure pump train in seawater desalination with an alternating electric field applied to engineered composite membranes, operating at atmospheric pressure.

Is AI about to replace your stock broker? Christine Healey, a pre-IPO investment expert, explains why Claude AI missed a critical detail in a deal that could have cost her client millions—and why human brokers are still essential in the private market. In this interview, Christine and Sean discuss the "wild west" of pre-IPO investing, how to avoid scams when buying shares of companies like SpaceX and Stripe, and the secret tax strategies (like the Peter Thiel Roth IRA hack) that can save you millions. They also debate whether employees selling shares before an IPO is a red flag or just smart financial planning. Check out the company: https://healeypreipo.com

Sara and Laura are obsessed with today's sweetie pie song, “Honey,” from The Life Of A Showgirl. After sharing some maternity leave updates for the podcast (and Sara's new obsession with Wuthering Heights!), the gals get into a short, sweet, and straightforward analysis of the song. Could this be the most Lover-coded song in Taylor's recent discography? This uncomplicated, confident track has the girls giggling and kicking their feet… especially knowing that Taylor's renewed sense of understanding love is so clear! Chapters(00:00) Introduction (04:02) What's On Our Plates(15:24) Taylor Updates(18:57) Analysis of 'Honey' from Life of a Showgirl(22:18) Our Personal Associations With The Song(23:42) Folk"lore" of the Song(29:15) Intro: Right To The Point, Interesting Structure Of the Song(31:09) Chorus 1: Using Kind Words For Unkind Reasons, Snarls, Bathroom Trauma (36:19) Post-Chorus 1: "Blues" Given New Meaning(39:50) Verse 1: Seasonal Dreaminess, Early Stages of A Relationship, A Question...? Reference(46:13) Verse 2: Naughty References, Wanting To See Him Everywhere, Public Relationship(49:34) Bridge: A Callback To Past Exes, "Lovely" As Passive Aggressive(53:45) Chorus 3: Fun Backing Vocals(54:47) Music Theory Analysis: Odd Structure Of The Song Symbolizes Confidence, Fun Instrumentation(57:58) Favorite Lyrics & Ratings(01:03:11) This Song As A Recipe(01:05:37) Signing Off!SUPPORT US ON PATREON! Show us some love and get monthly bonus episodes and first dibs on upcoming episode ideas. We'd be enchanted to have you join our Swiftie community!Links ReferencedBee's Knees Cocktail RecipePlease make sure to subscribe and leave a review. If you'd like to reach out to send in a question or comment, please do so via any of these platforms:email blankplatepod@gmail.comleave a voicemail at (717) 382-831Patreon (get bonus episodes and first dibs on episode ideas)YouTubeInstagramTikTokYou can also follow Sara and Laura individually:• Laura: Instagram and Tiktok• Sara: InstagramListen to our previous podcast: Passports & Pizza

If you have ever looked "fine" on the outside while feeling fried, foggy, or oddly disconnected from the business you used to love, this episode is for you. Early-stage burnout rarely announces itself. It shows up as low-grade anxiety, constant firefighting, and a calendar packed with things that do not actually move you toward your Vision. In this conversation, Erin and Steve name the real root of early-stage burnout: it is often not the number of things you are doing. It is the number of non–Vision-aligned things you are doing.  You will discover: Why burnout can start before you look "overwhelmed" on paper. How the Goal Swamp keeps you productive without feeling fulfilled. What "Static" is, and how to treat it like wisdom instead of a problem to eliminate. Why the first signs of burnout are often spotted by the people closest to you. The leadership skill nobody teaches: protecting your time and energy like it is sacred. You do not need to wait for a breakdown to change your week. You can spot early-stage burnout sooner, name what is actually happening, and make decisions that protect your life and your business.   Resources mentioned: Your Best Week For more support on stopping early stage burnout in your life, get Your Best Week, a five-day on-demand class designed for busy leaders and business owners who want their work to be supported by their life, not the other way around. If you have been telling yourself, "I just need to push through," this is your interruption. Your Vision is allowed to lead again.

Drs. Isaacs and Traina discuss new data in HER2+ breast cancer from the 2025 San Antonio Breast Cancer Symposium, focusing on early-stage studies including DESTINY-Breast11 and DESTINY-Breast05 and how data from these studies could potentially impact patient care in the future.

In this podcast, experts Mara Antonoff, MD, FACS; Laura Alder, MD; and Stephanie Worrell, MD, FACS, discuss the latest advances in immunotherapy and EGFR-targeted treatments for patients with resectable, early-stage, non–small cell lung cancer.

Vice President JD Vance told a crowd in central Wisconsin to re-elect Republican Derrick Van Orden. The state's 3rd Congressional District is a top target for Democrats. Wisconsin voters tell a pollster they're unlikely to support new school referendums.  And, Wisconsin Assembly Speaker Robin Vos says negotiations with the governor on a tax deal are still in the early stages. But he's optimistic.

This episode felt especially important to bring back.If you've ever found yourself emotionally attached too quickly, overlooking red flags, or confusing chemistry with compatibility, this conversation is for you.Inside this episode, I walk you through how to:Slow down without losing momentumStay emotionally grounded in the early stagesDate with intention instead of urgencyBuild real safety and discernment from the startIf dating has felt rushed, confusing, or emotionally draining lately, this is a powerful re-listen (or first listen).Ready to stop running from your emotions, rewire your attachment patterns, and embody secure attachment so you can have the kind of relationship where you are seen, heard, and loved, even on your worst days,I invite you to apply for my Private 1:1 Coaching container, Empowered Secure Love.Apply here:

In this episode of the HVAC Know It All Business Edition Podcast, co-hosts Gary McCreadie and Furman Haynes of WorkHero talk with Robyn Hass, Founder and Fractional CFO of Mainstreet MEP™ by HVAC Office Solutions and Trade Finance in Ten Podcast, and Fractional MEP CFO/CHRO, FP&A and Change Management Consultant of Robyn Hass Consulting. Robyn shares her journey of building Core Mechanical, a company that successfully scaled and was eventually sold to private equity. She discusses the importance of focus in business, financial systems, and the strategies behind scaling operations, particularly for those starting small in the HVAC industry. She offers invaluable insights on niche selection, managing overhead, and the systems and tools that were crucial for her company's success. Robyn also talks about how to support solo business owners and the challenges they face in managing their businesses effectively.    Expect to Learn: - Why focus is key when scaling your business and how choosing a niche helped Robyn's company grow. - The importance of financial systems and why investing in software like QuickBooks and field management tools early on can save you headaches later. - How to manage cash flow effectively and the overhead challenges that come with scaling. - Why it's crucial to train your technicians properly and capture all job data from day one. - Robyn's advice for solo entrepreneurs, why you don't always have to grow to be successful and how to partner with others. - The best ways to ensure financial health and how understanding your net margin is more important than EBITDA. - Robyn's new offerings for business owners, including resources, boot camps, and reporting tools to help scale more efficiently.   Timestamps: [00:00] - Introduction [02:05] - Starting Core Mechanical [04:04] - Importance of Focus in the Early Stages [05:20] - The Risk of Spreading Thin [07:29] - Challenges for Small Business Owners Doing Everything [08:29] - Setting Up Systems in the Early Days [10:08] - The Need for Proper Accounting and Software [12:50] - When to Hire and the Cash Flow Challenge [13:18] - Managing Cash Flow [14:23] - The Owner's Role in Scaling [15:51] - True Profit Margins and EBITDA [17:23] - The Difference Between EBITDA and Net Profit [19:24] - Setting Owner Salaries and Business Growth [21:20] - Thoughts on Cash Payments   Follow Robyn Hass: LinkedIn: https://www.linkedin.com/in/jrobynh/ Company LinkedIn: https://www.linkedin.com/company/mainstreet-mep Company Website: https://myhvacoffice.com/   Follow Gary McCreadie: LinkedIn: https://www.linkedin.com/in/gary-mccreadie-38217a77/ Website: https://www.hvacknowitall.com Facebook: https://www.facebook.com/people/HVAC-Know-It-All-2/61569643061429/   Follow Furman Haynes on: LinkedIn: https://www.linkedin.com/in/Furmanhaynes/ WorkHero: https://www.linkedin.com/company/workherohvac/ Instagram: https://www.instagram.com/hvacknowitall1/  

Republicans unveil the most extreme federal voting restrictions proposed in modern history, Tennessee officials are accused of quietly propping up a payday lender's failed sports betting operation, and scholars warn the U.S. may be entering the early stages of genocide against trans Americans.NewsNew GOP anti-voting bill may be the most dangerous attack on voting rights ever How a Tennessee Official Kept Advance Financial's Sports Betting Company AliveExperts Warn U.S. in Early Stages of Genocide Against Trans Americans Follow @PodSaveThePeople on Instagram.

This Week In Startups is made possible by:Quadratic - http://quadratic.ai/twistToday's show: Don't get distracted! Here are the MOST CRUCIAL aspects of running a startup, where founders need to keep their full and uninterrupted focus.- Make sure you're saving up your cash- Why you need to just get started and build SOMETHING- Trust and reliability is EVERYTHING for new products- Why distribution should be your top priorityDownload all this practical and tactical startup advice from seasoned veterans Jason Calacanis, Amanda Bradford, and William P. Barnes in this Tokyo edition of TWiST.Timestamps:(00:00) Amanda and Will's big takeaways from Founder U in Saudi Arabia and now Tokyo(3:19) Why cash flow management is so important before you find PMF(5:57) Why first-time founders get the order of operations wrong(6:45) Just build SOMETHING, even if it's taped together(11:19) “Focus is everything in the early stages”(14:17) From a wedge to a bridge(15:50) Quadratic - Bringing the productivity boost of AI into your spreadsheets. Visit http://quadratic.ai/twist to sign up and use the code TWIST to get one free month of their pro tier subscription.(18:45) What to put on your “Not Right Now” list(19:11) Embracing simplicity(22:00) The importance of trust and reliability (especially for Uber!)(28:12) Why innovation needs a constraining variable(33:40) To really drive word of mouth, you have to overdeliver(36:32) Distribution is the primary job of a founder/CEO(38:19) Some of the panel's favorite distribution hacks(45:54) Why Jason respects Japan's commitment to excellence and competency(49:38) Looking for “high slope” in early employees(53:11) Transitioning your team from early-stage startup to growth(57:45) Whoever writes it down gets credit for the idea(58:04) Q: Has the meaning of money changed for the panel now that they've had successful exits?*Subscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.com/Check out the TWIST500: https://twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcp*Follow Lon:X: https://x.com/lons*Follow Alex:X: https://x.com/alexLinkedIn: https://www.linkedin.com/in/alexwilhelm/*Follow Jason:X: https://twitter.com/JasonLinkedIn: https://www.linkedin.com/in/jasoncalacanis/*Thank you to our partners:(15:50) Quadratic - Bringing the productivity boost of AI into your spreadsheets. Visit http://quadratic.ai/twist to sign up and use the code TWIST to get one free month of their pro tier subscription.Check out all our partner offers: https://partners.launch.co/